Industry & Policy News

[Fred Hutchinson Cancer Center] A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred Hutch Cancer Center and Seattle Children’s Research Institute.

[University of Ottawa] Backed by a prestigious $3M Terry Fox New Frontiers Program Project Grant, Dr. Michele Ardolino and team will seek to uncover the hidden mechanisms of how the body’s immune system, nervous system, and gut microbiome interact in cancer,

[Medicenna Therapeutics, Corp.] Medicenna Therapeutics, Corp. announced NEO-CYT, a randomized, investigator‑initiated neoadjuvant trial testing MDNA11, a long‑acting, “beta‑enhanced not‑alpha” IL‑2 Superkine, in combination with nivolumab with or without ipilimumab for patients with high‑risk, surgically resectable Stage III cutaneous melanoma.

[University of Arizona] Two researchers from the University of Arizona Comprehensive Cancer Center and the College of Medicine—Tucson received $917,000 as part of a two-phase grant to investigate novel immune-based approaches to prevent keratinocytic skin cancers, which are the most common form of cancer in humans.

[Longeveron, Inc.] Longeveron, Inc. announced that the United States Patent and Trademark Office has granted a patent covering administration of the company’s proprietary MSCs for the treatment of patients with symptoms of aging-related frailty.

[UMC Utrecht] A team investigating the pediatric inflammatory disease juvenile dermatomyositis has received a €350,000 grant for the development of a model that more accurately can predict disease progress.